- Auxee AI for Healthcare
- Posts
- How to Expose AI Blindspots With These 4 Qs
How to Expose AI Blindspots With These 4 Qs
A candid note from a healthcare COO reveals four key questions to ask about AI in RCM.
Hi and happy Tuesday,
At 2:13 a.m., the COO of a 30-location specialty group replied to a short demo of an AI claim scrubbing tool.
“I don’t agree with the model... It feels too doctor-centric. But if your system is adaptable and scalable, I’ll give you 15 minutes.”
No pleasantries. No fluff. Just a direct callout of something that’s become a pattern: most “AI” tools still ask too much of already-stretched teams—and often solve the wrong problem.
That late-night message sparked a candid exchange that conveyed more than most webinars and whitepapers combined. And it left us with four questions every healthcare exec should be asking long before the pilot phase.
What every RCM leader should ask before saying yes to AI
Don’t ask product questions. First, ask operational ones about fit, flow, and what actually moves the needle.
1. Is it software, or is it support?
Most tools want you to bend your workflow around their features. But most teams don’t want another platform. They want silent support - something that works inside what they already use.
As that COO put it:
“Are you replacing our process or reinforcing it?”
In today’s environment, adaptability is key.
2. Does it address issues or just flag them?
Surface-level AI is everywhere. But pointing out a missed modifier isn’t the same as helping the team fix it, explain it, and learn from it.
The real ask: Can your staff act on what the system tells them, without bouncing between platforms, ticket queues, or third-party support?
3. Will it preserve knowledge, or create new training gaps?
With RCM turnover averaging 30%+ annually (Becker’s, 2024), teams are constantly rebuilding internal know-how. Good AI doesn’t just assist—it quietly teaches as it works.
If your team gets smarter just by using the tool, you’re investing in institutional memory, not just tech.
4. Has it actually delivered results?
This isn’t theoretical. One multi-site group that asked these same questions found the right fit and saw:
$668K in annual savings
Denials down from 16% to 7%
Chart corrections cut by 40%+
That’s not from a revamp. It was from AI running in the background, reviewing every chart before it became a problem.
Why these questions matter more now than ever
It’s not just about smarter software. It’s about systems thinking in a new era of reimbursement.
Over the past year, payers have quietly introduced tighter logic checks, expanded documentation requirements, and increased scrutiny on even routine procedures. But most teams haven’t updated their workflows to match.
What’s changing:
Payer rules are evolving faster than staff training cycles.
Many denials now stem from subtle updates buried in provider bulletins - things your team didn’t miss because they were careless, but because the information never reached them in time.Generic AI tools don’t interpret narrative context.
Tools not trained on medical nuance miss key decision points hidden in free-text notes. That’s where true claim risk lives and why most off-the-shelf automation fails to reduce denials in any meaningful way.Internal QA teams are reaching their bandwidth limits.
Even with talented people, most review processes can’t scale fast enough to keep up with increasing volume, let alone the complexity. It's not about working harder, but more about creating leverage.
📊 Case in point:
A 2024 MGMA report found that at mid-sized group practices, up to 32% of all RCM labor hours are spent on reworking claims.
And the top-cited reason?
Upstream documentation errors were missed during the initial review.
Self-assess your AI readiness - using ChatGPT (or your favorite chatbot)
If you’re exploring AI for your revenue cycle, here’s a fast way to gauge whether your current process is ready to benefit or if it might just automate chaos.
Step 1: Answer these 5 questions honestly.
Just 1–2 sentences each is enough.
Where in your claims process do humans still have to double-check something before submission?
When a denial comes in, how long does it take to trace it back to the original chart or note?
What’s the most common reason for rework or appeals today?
How do you onboard new RCM staff, and how long until they’re fully effective?
What would you want AI to help with most—speed, consistency, or coverage?
Step 2: Paste this prompt into ChatGPT or Claude with your answers.
I'm evaluating our readiness to adopt AI in our revenue cycle process. Here are 5 short answers about how we currently operate:
[paste in the questions & answers]
Can you assess our AI readiness based on this? Identify any blind spots, potential risks, or process gaps, and suggest low-lift changes to improve our readiness.
That’s it! No vendors. No worksheets. Just a better sense of where your RCM stands and what to fix first. If you try it out, let us know how it goes.
Bonus follow-up question - ask ChatGPT: Can Auxee AI be a solution for me?
If the answer is yes, we should talk!
The best AI isn’t just smart, it’s invisible.
The most effective solutions don’t announce themselves. They don’t ask your team to do more. They quietly lift the burden of repetitive checks, freeing up time and attention for edge cases and exceptions.
So, if your team is still relying on people to manually interpret notes, track down codes, and piece together payer rules, the real risk isn’t just inefficiency, it’s fragility.
One staff departure, one policy change, or one missed update, and the whole system wobbles.
Next week, I’ll reveal the operational leak no one’s budgeting for, and how smarter scrubbing is changing that.
See you next Tuesday,
Dino Gane-Palmer
That's it for today!Before you go we’d love to know what you thought of today's newsletter to help us improve the experience for you. |
![]() Dino Gane-Palmer | About the Author Dino Gane-Palmer is the founder of Auxee and CEO of PreScouter, an Inc. 5000–recognized innovation consultancy that helps Fortune 500 companies and global organizations capitalize on new markets and emerging technologies. He launched PreScouter while earning his MBA at Kellogg and later founded Auxee to help teams use AI to tackle complex, research-heavy workflows. His work has supported decisions at some of the world’s leading healthcare, manufacturing, and consumer brands. Dino is also the author of the best-selling book Do More With Less: The AI Playbook, a practical guide to applying AI where it matters most. |
